Our data give insight into a molecular cross-talk between the MID1-α4-PP2A complex and GLI3, paving the way to a molecular explanation for the loss-of-function phenotype in GCPS patients with C-terminal missense mutations. The gene discussed is MID1; the disease is Greig cephalopolysyndactyly syndrome.